How a Portuguese Health Startup Is Quietly Reshaping Remote Care in Europe

Jan de Vries · 2026-09-08

Let's talk about something that doesn't get nearly enough attention: the behind-the-scenes tech that's keeping people out of hospital beds. Hope Care, a Portuguese digital health company, just closed a $6.4 million Series A round (converted from €6 million) to push its remote patient monitoring platform deeper into Europe. And honestly, the numbers they're sharing are pretty eye-opening. The funding was led by Iberis Capital, with support from Vieira de Matos – VDM Capital, S.A. and existing backer Buenavista Equity Partners. It's not the flashiest headline in the startup world, but for anyone tracking how healthcare systems are evolving, this is a meaningful signal. ### What Hope Care Actually Does Founded back in 2012, Hope Care built a platform called OpMA. It's a regulated system that powers centralized remote care and telehealth centers. Think of it as the connective tissue between medical devices, patient-reported outcomes, and clinical workflows. Instead of juggling multiple tools, healthcare organizations get one environment to design, launch, and scale digital care programs for chronic conditions. The key word here is "regulated." That's not just bureaucratic noise. It means the platform meets the standards required to operate inside public health systems, which is a much higher bar than consumer health apps have to clear. ### The Proof Is in the Results Here's where it gets interesting. Hope Care shared data from a 12-month analysis involving 43 people with chronic obstructive pulmonary disease (COPD). The program was linked to a 76% reduction in hospital days and a 74% drop in emergency department visits. That translated to estimated annual savings of about $5,200 per patient. Let that sink in for a second. We're not talking about a small pilot or a theoretical model. These are real-world outcomes that show proactive care can actually move the needle on costs and quality of life. ### Where They're Expanding Hope Care isn't just talking about growth; they're already operating in multiple markets. Here's a quick snapshot of their current footprint: - **Portugal**: Their tech is used by 15 Local Health Units, covering roughly 45% of all registered SNS users, plus the Regional Health Services of Madeira and the Azores. - **France**: Active remote monitoring programs, including within GHT Saône-et-Loire Bresse Morvan. - **Switzerland**: A project is currently underway. - **Germany**: They've set up Hope Care GmbH at Medical Valley in Erlangen, with the first deployment slated for October 2026. - **Romania**: A new project is advancing, with local setup activities starting by the end of September 2026. That's a pretty aggressive expansion plan for a company that's been quietly building for over a decade. ### Why This Matters for the Broader Healthcare Conversation Across Europe, health systems are buckling under the weight of chronic disease. Too often, they're responding to crises instead of preventing them. João Henriques, Partner at Iberis Capital, put it well: "Hope Care is one of the few companies that pairs proven clinical evidence with the regulatory maturity to operate inside public health systems at scale." That combination is rare. Lots of startups have slick demos. Very few can walk into a public hospital network and actually integrate with existing workflows while meeting regulatory requirements. ### What's Next for Hope Care The company plans to use this capital to strengthen its commercial and operational capabilities, and to accelerate deployments in key healthcare markets. They're also seeing strong momentum: first-half sales in 2026 hit 2.5 times the level from the same period in 2025. José Paulo Carvalho, founder and CEO, summed up the mission: "After more than a decade working with healthcare institutions, we have built a regulated platform that delivers measurable outcomes for patients, healthcare professionals and healthcare systems." It's a reminder that some of the most impactful health tech isn't about flashy consumer apps. It's about making the existing system work better, one patient at a time.